Table 1

Characteristics of poststroke study population

N (%)N (%)
Total45 474 (100)45 474 (100)
Total person-years from study start date to end of follow-up (1000s)148.371Alcohol status
Age at first incident stroke (years) Non-drinker4914 (10.8)
 40 to 597527 (16.6) Current-drinker29 044 (63.9)
 60 to 7414 578 (32.1) Ex-drinker6447 (14.2)
 75 to 8414 026 (30.8) Missing5069 (11.1)
 Over 859343 (20.5)BMI category WHO defined
Sex Underweight1235 (2.7)
 Male23 196 (51) Normal Weight13 782 (30.3)
 Female22 278 (49.0) Overweight15 146 (33.3)
Ethnicity Obese10 318 (22.7)
 Black543 (1.2) Missing4993 (11.0)
 Mixed/Other520 (1.1)Current smoker
 South Asian885 (1.9) No35 461 (78.0)
 White43 526 (95.7) Yes8781 (19.3)
Dementia diagnosed in study period, excluding first 3 months Missing1232 (2.7)
 No40 850 (89.8)Myocardial Infarction prior to stroke
 Yes4624 (10.2) No41 887 (92.1)
Index of Multiple Deprivation (1 is least deprived) Yes3587 (7.9)
 17273 (16.0)Atrial fibrillation prior to stroke
 28407 (18.5) No39 449 (86.8)
 39776 (21.5) Yes6025 (13.2)
 49125 (20.1)Uncontrolled diabetes prior to stroke
 510 893 (24.0) No42 857 (94.2)
Statin prescription 2 years prior to stroke Yes2617 (5.8)
 No29 599 (65.1)Consultations per year in 3 years prior to stroke
 Yes15 875 (34.9) <10 per year25 399 (55.9)
Uncontrolled HT (Sys≥140 and Dias≥90 mm Hg)—2 years prior to stroke 10–20 per year12 962 (28.5)
 No40 710 (89.5) 20–30 per year4496 (9.9)
 Yes4764 (10.5) 30–50 per year2220 (4.9)
Immunosuppressive prescription 2 years prior to stroke >50 per year397 (0.9)
 No40 375 (88.8)Patient has HES linkage
 Yes5099 (11.2) No7089 (15.6)
Antiplatelets within 90 days of stroke onset Yes38 385 (84.4)
 No18 308 (40.3)
 Yes27 166 (59.7)
  • BMI, body mass index.